AACR Conference Coverage
Featured Articles
(Johns Hopkins Medicine) Apr 3, 2019 - Due to advances in treatment, an ever-increasing number of patients are living longer as metastatic cancer survivors. They and their doctors face a host of new challenges that require immediate attention. It used to be when you were diagnosed with metastatic cancer, you were told to get your...
Read Article
(BMS) Apr 2, 2019 - Bristol-Myers Squibb Company today announced results from pooled analyses of survival data from four studies (CheckMate -017, -057, -063 and -003; n=664) in patients with previously-treated advanced non-small cell lung cancer (NSCLC) who were treated with Opdivo (nivolumab). In the pooled analysis of the four...
Read Article
Latest Articles
April 05, 2019
April 04, 2019
April 04, 2019
April 03, 2019
April 03, 2019
April 03, 2019
April 03, 2019
April 03, 2019
View More
News Commentary
Editor Image
03 Apr, 2019 | by H. Jack West, MD
Nice to see further long-term survival data, really in keeping with what we've...
View Comment
Editor Image
02 Apr, 2019 | by Tomasz M. Beer, MD
A badly misleading title. This study could not determine if survival is...
View Comment
View More
Featured Videos
There are no videos.
OBR Blog
Facts first, then comments. Keynote -189: This phase III trial compared pembrolizumab (pembro), or placebo, plus... Read more
April 17, 2018
A pre-meeting webinar provided a glimpse of some of the key presentations at the upcoming annual meeting of the... Read more
March 16, 2018

OBR Tweets

Mar 30
H. Jack West, MD: This provides another option that is pretty much a lateral move compared to atezolizumab with che… https://t.co/hnkRD0AfXw

Mar 26
Howard S. Hochster, MD: There is no question that SARS-CoV-2 will prove to be a major challenge to all health care… https://t.co/EyJijktM68

Mar 25
OBR speaks to providers at community oncology practices like Florida Cancer Specialists & Research Institute (FCS)… https://t.co/3qyne3w9gE

Mar 25
Dr. David Penson of Vanderbilt University Medical Center @VUmedicine delves into Financial toxicity and its negativ… https://t.co/o2IUnKvcff

Mar 25
Dr. Azra Raza @AzraRazaMD, an Oncologist at @Columbia, speaks to us about her recently published book @thefirstcell… https://t.co/x1HmTvHta7

Mar 25
H. Jack West, MD: An excellent piece that highlights what the history of cancer research should be teaching the wor… https://t.co/QAEpZJP8ov

Mar 24
Preparing your Oncology Clinic for COVID-19 Infections - Webinar Archive Now Available https://t.co/CV2a4q4DUl ft.… https://t.co/KvibaK0WdL

Mar 18
H. Jack West, MD: The CASPIAN trial was positive for a survival benefit with durvalumab added to platinum/etoposide… https://t.co/gdMU91vjN1

Mar 16
William McGivney, PhD: I know that I quoted that health care policy sage, Yogi Berra, a few commentaries ago, but h… https://t.co/h1xFemYuf9

Mar 13
Melody Chang, RPh, MBA, BCOP, of Florida Cancer Specialists elaborates on 340B's affect on pharmacy operations at F… https://t.co/RcEJlDtAhw